Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

MSF medical team in Matsenjeni health centre, Nhlangano, Eswatini. Photo by MSF/Jakub Hein
Press release
Press release |
03 February 2021
COVID-19
EswatiniMalawiMozambique

MSF: Urgent need for vaccines as new COVID-19 strain ravages Mozambique, Eswatini and Malawi

South African activists protest in support of the WTO TRIPS Waiver Photo by Tadeu Andre
Press release
Press release |
03 February 2021
COVID-19

MSF to wealthy countries: Don’t block and ruin the potential of a landmark waiver on monopolies during the pandemic

4 min
Alix Bommelear is an MSF doctor working in a mobile clinic in the north of Paris. She spends her days providing medical care to homeless people, most of whom are migrants or refugees who cannot access medical care elsewhere. Photo by Corentin Fohlen
Press release
Press release |
29 January 2021
COVID-19

MSF response to release of Johnson & Johnson COVID-19 vaccine data

An MSF mobile team travels through southeastern Mexico to provide humanitarian medical assistance to hundreds of people entering the country, including preventive measures against COVID-19. Photograph by Yesika Ocampo
Press release
Press release |
29 January 2021
COVID-19

COVID-19 diagnostics: MSF welcomes more affordable rapid tests for lower- and middle-income countries

3 min
In addition to mobile clinics targeting people living in homelessness, in partnership with the city of Rio de Janeiro, MSF conducted health promotion, screening and medical care activities at a low-cost restaurant in Bonsucesso. Photograph by Mariana Abdalla
Press release
Press release |
22 January 2021
COVID-19

COVID-19 vaccines: MSF deplores just 2% of Pfizer’s 2021 & 2022 supply going to COVAX Facility

4 min
Sister Zethembiso Majola reads out thank you letters from the first COVID-19 patients to be discharged from the Livingstone Hospital basement ward, a COVID-19 ward for high acuity patients that could not have been opened without the support of MSF. Photograph by MSF South Africa
Press release
Press release |
15 December 2020
COVID-19

Governments must act fast on consensus supporting historic move to suspend monopolies during pandemic

4 min
MSF’s medical staff review patient files during the ward round in the MSF Hospital in the Bentiu Protection of Civilian (PoC) site. Since the COVID-19 pandemic reached South Sudan, MSF has to reduce its inpatient bed capacity to adhere to preventive measures. Photograph by Tetiana Gaviuk
Press release
Press release |
08 December 2020
COVID-19

Pfizer and Moderna vaccines can only be scaled up globally if many more suppliers can produce

"" Photograph by Khan Yunis
Press release
Press release |
25 November 2020
Intellectual property and trade

MSF welcomes EU pharmaceutical strategy but challenges key intellectual property issue

2 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury